FDA provides $150,000 for safety, efficacy testing in aquatic medicine

Printer-friendly version

Federal authorities gave $150,000 to support studies on the effectiveness of a treatment for fungal disease in walleye and the safety of a medicated feed for shrimp.

The Food and Drug Administration announced Nov. 2 the studies were funded through grants intended to support development of new animal drugs for minor species or minor uses in major species.

Researchers at the U.S. Geological Survey's Upper Midwest Environmental Sciences Center in La Crosse, Wis., were awarded about $50,000 for a study on the use of hydrogen peroxide to control saprolegniasis, a fungal disease of walleye.

And researchers at the Agrilife Research Mariculture Laboratory in Port Aransas, Texas, were awarded about $100,000 for a study on the use of oxytetracycline in medicated shrimp feed.

The grant program was established through the Minor Use and Minor Species Animal Health Act of 2004, and Congress appropriated money to support the program in March 2009. The grants are intended to defray costs of safety or effectiveness testing in development of new animal drugs.

Return to top